Total Raised

$3.12M

Investors Count

5

Funding, Valuation & Revenue

6 Fundings

Genome Compiler has raised $3.12M over 6 rounds.

Genome Compiler's latest funding round was a Acquired for on April 6, 2016.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

4/6/2016

Acquired

$XXM

0

FY undefined

3

9/18/2015

Seed

$XXM

$XXM

0

FY undefined

10

4/29/2014

Unattributed VC

$XXM

0

FY undefined

10

10/30/2012

Corporate Minority

$XXM

$XXM

0

FY undefined

10

10/30/2012

Angel

$XXM

$XXM

0

FY undefined

10

Date

4/6/2016

9/18/2015

4/29/2014

10/30/2012

10/30/2012

Round

Acquired

Seed

Unattributed VC

Corporate Minority

Angel

Amount

$XXM

$XXM

$XXM

Investors

Valuation

$XXM

$XXM

$XXM

$XXM

$XXM

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

3

10

10

10

10

Start free trial
New call-to-action

Genome Compiler Investors

5 Investors

Genome Compiler has 5 investors. Twist Bioscience invested in Genome Compiler's Acquired funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

4/6/2016

4/6/2016

1
Acquired

Corporation

California

00/00/0000

00/00/0000

NFX

Subscribe to see more

Venture Capital

California

00/00/0000

00/00/0000

Foundry

Subscribe to see more

Venture Capital

Colorado

00/00/0000

00/00/0000

Autodesk

Subscribe to see more

Corporation

California

LionBird

Subscribe to see more

Venture Capital

Israel

First funding

4/6/2016

00/00/0000

00/00/0000

00/00/0000

Last Funding

4/6/2016

00/00/0000

00/00/0000

00/00/0000

Investor

NFX

Foundry

Autodesk

LionBird

Rounds

1
Acquired

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Type

Corporation

Venture Capital

Venture Capital

Corporation

Venture Capital

Location

California

California

Colorado

California

Israel

New call-to-action

Compare Genome Compiler to Competitors

Eligo Bioscience Logo
Eligo Bioscience

Eligo Bioscience is a biotechnology company that develops biotherapeutics for the editing of the microbiome. The company provides a platform for gene editing of the microbiome to address various diseases. Eligo Bioscience serves the biotechnology and pharmaceutical sectors with its gene editing solutions. It was founded in 2014 and is based in Paris, France.

Amyris Logo
Amyris

Amyris operates as a biotechnology company. It focuses on transforming plant-derived sugars into molecules used in different industries. The company provides services in strain development, process development, piloting, and scale-up, and also manufactures sustainable ingredients. Amyris serves sectors including industrials, pharmaceuticals, flavors and fragrances, and beauty, health, and wellness. Amyris was formerly known as Amyris Biotechnologies. It was founded in 2003 and is based in Emeryville, California. In August 2023, Amyris filed for bankruptcy.

C
Codon Devices

Codon Devices is engaged in the field of synthetic biology.

Synthego Logo
Synthego

Synthego is a genome engineering company focused on life science research and development within the healthcare sector. The company offers platforms that integrate machine learning, automation, and gene editing to facilitate genome editing at scale. It was founded in 2012 and is based in Redwood City, California. In May 2025, Synthego filed for bankruptcy.

Twist Bioscience Logo
Twist Bioscience

Twist Bioscience is a synthetic biology company specializing in the production of synthetic DNA through a proprietary silicon-based manufacturing process. The company offers products including gene synthesis, oligo pools, and next-generation sequencing (NGS) target enrichment solutions, aimed at life science research and fields such as medicine, agriculture, and data storage. Twist Bioscience serves researchers needing effective DNA synthesis and sequencing solutions. It was founded in 2013 and is based in South San Francisco, California.

Ginkgo Bioworks Logo
Ginkgo Bioworks

Ginkgo Bioworks operates within multiple sectors, including agriculture, biopharma, biosecurity, government, and industrial biotech. The company offers a cell programming platform that includes tools such as artificial intelligence models, data generation, and lab automation, as well as solutions for various industries. It serves sectors that require biotechnological research and development, such as agriculture for crop protection and nutrition, biopharma for genetic medicines, and industrial biotech for ingredients and chemicals. The company was founded in 2009 and is based in Boston, Massachusetts.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.